Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period

References

• Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317.
   PubMed Web of Science ®Google Scholar
• Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP and National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 2002; 35: 627–630.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, . and the Invasive Fungal Infection Group of the EORTC. Candidemia in cancerpatients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071–1079.
   PubMed Web of Science ®Google Scholar
• White SJ, Rosenbach A, Lephart P, . Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 2007; 3: 1866–1878.
   Google Scholar
• Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet 2002; 359: 1135–1144.
   PubMed Web of Science ®Google Scholar
• Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 2007; 59: 767–771.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27–A2, 2nd. Stockholm: Informa Healthcare, 2000
   Google Scholar
• Nguyen MH, Clancy CJ, Yu VL, . Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis 1998; 177: 425–430.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Perkhofer S, Mayr A. In vitro susceptibility testing in fungi: a global perspective on a variety of methods. Mycoses 2010; 53: 1–11.
   PubMed Web of Science ®Google Scholar
• Alexander BD, Byrne T, Smith K . Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007; 45: 698–706.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
   PubMed Web of Science ®Google Scholar
• Yang YL, Cheng HH, Lo HJ. Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol 2006; 44: 237–242.
   PubMed Web of Science ®Google Scholar
• González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 2008; 46: 2902–2905.
   PubMed Web of Science ®Google Scholar
• Swoboda-Kopec E, Kawecki D, Wroblewska M, Krawczyk M, Luczak M. Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of Warsaw. Transplant Proc 2003; 35: 2298–2303.
   PubMedGoogle Scholar
• Hautala T, Ikäheimo I, Husu H, . A cluster of Candida krusei infections in a haematological unit. BMC Infect Dis 2007; 7: 97–104.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Rinaldi MG, . Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005; 43: 5848–5859.
   PubMed Web of Science ®Google Scholar
• Yang YL, Cheng MF, Wang CW, . The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol 2009; 5: 1–7.
   Google Scholar
• Borg-von Zepelin M, Kunz L, Rüchel R, . Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother 2007; 60: 424–428.
   PubMedGoogle Scholar
• Tan TY, Tan AL, Tee NW, Ng LS. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann Acad Med Singapore 2008; 37: 835–840.
   PubMed Web of Science ®Google Scholar
• St-Germain G, Laverdière M, Pelletier R, . Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: report on 453 cases between 2003 and 2005. Can J Infect Dis Med Microbiol 2008; 19: 55–62.
   PubMed Web of Science ®Google Scholar
• Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses 2007; 50: 52–57.
   PubMedGoogle Scholar
• Dizbay M, Fidan I, Kalkanci A, . High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. Scand J Infect Dis 2010; 42: 114–120.
   PubMed Web of Science ®Google Scholar
• Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606–625.
   PubMed Web of Science ®Google Scholar
• Fadda ME, Podda GS, Pisano MB, Deplano M, Cosentino S. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey. J Prev Med Hyg 2008; 49: 69–74.
   PubMedGoogle Scholar
• Martin D, Persat F, Piens MA, Picot S. Candida species distribution in bloodstream cultures in Lyon, France, 1998–2001. Eur J Clin Microbiol Infect Dis 2005; 24: 329–333.
   PubMedGoogle Scholar
• Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 2004; 25: 60–64.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Mayr A, Perkhofer S, . Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2008; 52: 3637–3641.
   PubMed Web of Science ®Google Scholar